Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Jun 30, 2016

29777_dirs_2016-06-30_47a56b6b-184d-4c12-81de-f5cf2f82ed67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-06-28

Reporting Person: ALLEN HUBERT L (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-28 Common shares without par value M 3400 $20.7485 Acquired 91857 Direct
2016-06-28 Common shares without par value S 3400 $37.14 Disposed 88457 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-28 Option (right to buy) $20.7485 M 3400 Disposed 2016-06-29 Common shares (3400) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.